Cogent Biosciences Inc. (NASDAQ: COGT) announced that results from its Phase 3 PEAK trial will be presented at the 2026 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE